Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT03069105
  4. Details
NCT03069105 Clinical Trial

An Exploratory Study of Caregiver Burden Among Family Caregivers of Patients With Cancer

Cancer Clinical Trial

Official title:
An Exploratory Study of Caregiver Burden Among Family Caregivers of Cancer Patients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03069105
Other study ID # JWCI-16-1201
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 23, 2017
Est. completion date April 28, 2020

Study information
Verified date November 2020
Source John Wayne Cancer Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will look at caregiver burden and the coping behavior of caregivers of patients with cancer. Through this study, the investigators will identify the relationship between cognitive dysfunction (measured as a proxy rating by the caregiver), resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer.

Description:

The goal of this study is to explore caregiver burden and the coping behavior of caregivers of patients with cancer. It has been documented that non-professional caregivers and long-term care providers to patients with cancer receive little preparation, information, or support to perform their vital role. Through this study, the investigators will identify the relationship between cognitive dysfunction, resilience, social support, cognitive appraisal, coping behavior, and caregiver burden, anxiety, and depression among family caregivers of patients with cancer. The findings of this study will direct future intervention studies to reduce caregiver burden and improve outcomes for the many individuals caring for family members with cancer.

Recruitment information / eligibility
Status Completed
Enrollment 49
Est. completion date April 28, 2020
Est. primary completion date April 28, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Self-identified primary caregiver of patients with cancer - Co-residence with the patient - Providing a minimum of 4 hours of direct care for at least 3 days per week - Able to speak, read, and understand English - Willing to participate in completion of surveys Exclusion Criteria: - Professional or paid caregivers

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Questionnaire
Participants will complete paper and pencil or electronic questionnaires at the cancer center or in the privacy of their own homes.

Locations
Country Name City State
United States Providence Saint Joseph Medical Center Burbank California
United States Providence Holy Cross Medical Center Mission Hills California
United States EndBrainCancer Initiative/Chris Elliott Fund Redmond Washington
United States John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica California

Sponsors (1)
Lead Sponsor Collaborator
John Wayne Cancer Institute

Country where clinical trial is conducted

United States, 

References & Publications (2)

Saria MG, Courchesne N, Evangelista L, Carter J, MacManus DA, Gorman MK, Nyamathi AM, Phillips LR, Piccioni D, Kesari S, Maliski S. Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and coping. Support Care Cancer. 2017 Apr;25(4):1247-1256. doi: 10.1007/s00520-016-3517-3. Epub 2016 Dec 5. — View Citation

Saria MG, Nyamathi A, Phillips LR, Stanton AL, Evangelista L, Kesari S, Maliski S. The Hidden Morbidity of Cancer: Burden in Caregivers of Patients with Brain Metastases. Nurs Clin North Am. 2017 Mar;52(1):159-178. doi: 10.1016/j.cnur.2016.10.002. Review. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Changes in Caregiver Burden Score [Caregiver Reaction Assessment (CRA)] Relation between caregiver burden subscale scores and caregiver resilience, social support, and coping 1 year
Secondary Changes in Anxiety and Depression Score [Hospital Anxiety and Depression Scale (HADS)] Relation between caregiver anxiety and depression score and caregiver resilience, social support, and coping 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients